FactSet Research Systems Inc. vs CME Group Inc.
A head-to-head of FactSet Research Systems Inc. (FDS) and CME Group Inc. (CME) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | FDS | CME |
|---|---|---|
| Market Cap | $9.18B | $88.54B |
| P/E (TTM) | 17.00 | 20.98 |
| Forward P/E | 13.12 | 23.53 |
| P/S | 3.48 | 15.29 |
| P/B | 5.49 | 3.34 |
| EV/EBITDA | 9.69 | 16.89 |
| Dividend Yield | 1.47% | 4.57% |
| Profit Margin | 23.21% | 62.77% |
| Gross Margin | 52.72% | 86.09% |
| Operating Margin | 32.23% | 64.86% |
| Revenue Growth (YoY) | +6.39% | +14.48% |
| FCF Yield | 8.17% | 4.20% |
| Debt / Equity | 68.38 | 13.07 |
| Current Ratio | 0.68 | 1.02 |
Which is better: FactSet Research Systems Inc. or CME Group Inc.?
- ✓Larger by market cap: CME Group Inc.
- ✓Cheaper valuation (lower P/E): FactSet Research Systems Inc.
- ✓Higher dividend yield: CME Group Inc.
- ✓More profitable (net margin): CME Group Inc.
- ✓Faster revenue growth: CME Group Inc.
- ✓Higher free-cash-flow yield: FactSet Research Systems Inc.
Across 13 available metrics, CME Group Inc. leads 8–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.